69$/KG
liposomal Magnesium Lactate 80% is a premium-grade dietary supplement ingredient delivering magnesium lactate in an advanced liposomal delivery system. Magnesium lactate (CAS 18917-93-6 for anhydrous; CAS 179308-96-4 for octahydrate) is the magnesium salt of lactic acid, chemically characterized by the molecular formula C₆H₁₀MgO₆ (anhydrous) and a molecular weight of 202.45 g/mol. The octahydrate form has a molecular weight of 238.48 g/mol. It is a white crystalline or granular powder that is practically odorless, has a neutral taste, and is soluble in water with good solubility (84 g/L).
Magnesium is the fourth most abundant cation in the human body and serves as an essential cofactor for more than 300 enzymatic reactions, including all enzymatic processes involving ATP. It plays a critical role in neurochemical transmission and muscular excitability, and is essential for maintaining normal bone density, cardiac rhythmicity, pulmonary function, and blood glucose regulation. Magnesium lactate is widely utilized in pharmaceutical and nutraceutical formulations due to its high bioavailability, neutral taste, and excellent gastrointestinal tolerability. The lactate component provides an additional benefit—it is a natural energy source that muscles and the heart utilize directly.
Magnesium lactate already offers superior bioavailability compared to inorganic magnesium salts. A landmark comparative bioavailability study in normal volunteers demonstrated that magnesium oxide had a fractional absorption of only 4%, while magnesium lactate showed significantly higher absorption equivalent to magnesium chloride and magnesium aspartate. However, even well-absorbed magnesium salts face challenges related to the saturable nature of intestinal magnesium transport and the potential for gastrointestinal discomfort at higher doses.
Liposomal encapsulation provides four critical advantages:
1. Superior Bioavailability and Sustained Plasma Levels — A randomized, controlled, two-group human clinical trial in 20 metabolically healthy volunteers compared the bioavailability of 400 mg magnesium in liquid liposomal form versus non-liposomal tablet form. The liquid liposomal magnesium supplement achieved up to 5.18 times higher bioavailability than the non-liposomal tablet form. Liposomal magnesium also maintained elevated plasma levels throughout the entire study period, demonstrating sustained high concentrations during daily supplementation.
2. Enhanced Cellular Uptake — liposomes fuse directly with intestinal cell membranes, facilitating efficient cellular delivery via lipid-mediated pathways. The liposomal delivery system bypasses the saturable nature of carrier-mediated magnesium transport, providing an alternative route of cellular entry.
3. Gastrointestinal Protection — The phospholipid bilayer shields the magnesium-lactate complex from premature interaction with gastric contents, minimizing direct contact between magnesium and the gastrointestinal mucosa. Magnesium lactate is already known for its lack of laxative side effects compared to magnesium oxide and citrate, and liposomal encapsulation further enhances tolerability.
4. Neutral Taste and Excellent Dispersibility — Magnesium lactate has a neutral taste and is practically odorless. Liposomal encapsulation provides excellent water dispersibility, making it suitable for a wide range of beverage and liquid formulations.
| Field | Details |
|---|---|
| Product Name | Liposomal Magnesium Lactate 80% |
| CAS No. | 18917-93-6 (anhydrous); 179308-96-4 (octahydrate) |
| Active Ingredient | Magnesium Lactate |
| Assay Method | USP complexometric titration with 0.05 M edetate disodium (EDTA) for magnesium determination; alternative method: ion-exclusion HPLC with refractive index detection (HPLC-RI) or atomic absorption spectroscopy (AAS) for elemental magnesium content; ICP-MS for heavy metal analysis. Food Chemicals Codex (FCC) monograph specifies assay of 97.5%–101.5% for magnesium L-lactate on the dried basis |
| Purity | ≥ 80% magnesium lactate; elemental magnesium ≥ 12.0% |
| Appearance / Color | White to off-white crystalline or granular powder |
| Odor | Practically odorless; neutral taste |
| Dosage Form | Liposomal powder, water-dispersible |
| Recommended Dosage | 200–400 mg elemental magnesium per day; clinical trials have used 336 mg/day (slow-release magnesium lactate) and 504 mg/day (magnesium L-lactate in ICD patients) |
| Application | Muscle relaxation and cramp relief, Energy Metabolism, nervous system support, cardiovascular health, bone health, stress management, electrolyte balance |
| Extract Source | Synthetic (lactic acid neutralized with a high-purity magnesium source followed by precipitation and drying); sunflower phospholipid liposomal carrier system |
| Molecular Formula | C₆H₁₀MgO₆ (anhydrous); C₆H₁₀MgO₆·8H₂O (octahydrate) |
| Molecular Weight | 202.45 g/mol (anhydrous); 238.48 g/mol (octahydrate) |
| Lead Time | In stock: 3–5 business days; Bulk/custom orders: 2–3 weeks |
| Shipping Method | International Express (FedEx / DHL / UPS); air and sea freight available; worldwide shipping including remote areas |
| Storage | Store in a cool, dry place away from direct sunlight and moisture; keep container tightly sealed. Shelf life: 24 months |
| Packaging | 1 kg/aluminum foil bag with two plastic bags inside; 25 kg/carton or fiber drum with aluminum foil bag inside |
High Purity — Standardized to ≥80% magnesium lactate, with elemental magnesium content of ≥12.0%.
Liposomal Enhancement — Phospholipid bilayer encapsulation achieves up to 5.18 times higher bioavailability compared to non-liposomal magnesium in tablet form in human clinical study, with sustained elevated plasma levels.
Superior Bioavailability — Magnesium lactate demonstrates significantly higher absorption than magnesium oxide, with bioavailability equivalent to magnesium chloride and magnesium aspartate in comparative clinical studies.
GRAS and FDA Affirmed — Magnesium lactate is self-affirmed Generally Recognized As Safe (GRAS) up to 20% of the daily value of magnesium when used in fortified food and beverages and is in full compliance with the US FDA. FDA GRAS Notice GRN 570 covers its use as a source of dietary magnesium in fruit-flavored beverages.
No Laxative Side Effects — Magnesium lactate is absorbed more easily by the intestines compared to oxide or other inorganic forms, without the laxative side effects commonly associated with magnesium oxide and citrate.
Synergistic Lactate Benefit — The lactate component binds to lactic acid, a natural energy source utilized by muscles and the heart.
Clinically Studied for Muscle Cramps — Clinical trials have used 336 mg/day of slow-release magnesium lactate and 366 mg/day from primarily magnesium lactate and magnesium citrate tablets for skeletal muscle cramp relief.
Water-Dispersible — Good solubility in water (84 g/L); neutral taste and practically odorless; suitable for capsules, tablets, powder drink mixes, and functional beverages.
Batch Traceability — Complete COA, HPLC chromatogram, and identity data provided for each batch.
| Application | Recommended Usage | Notes |
|---|---|---|
| Capsules / Tablets | 100–200 mg elemental magnesium per serving | 2 tablets daily (providing 200 mg elemental magnesium); take with meals |
| Functional Beverages | 50–100 mg per 250 mL | Water-soluble; neutral taste |
| Powdered Drink Mixes | 200–400 mg per sachet | Blend with vitamin B6 for enhanced cellular uptake |
| Muscle Cramp Relief Formulas | 300–400 mg per serving | Clinical trials used 336 mg/day slow-release magnesium lactate |
| Liposomal Liquid Formulations | 200 mg elemental magnesium per 15 mL dose | Commercial liposomal products typically recommend 15 mL once daily for adults |
| Energy Metabolism Formulas | 100–200 mg per serving | Often combined with CoQ10 or L-carnitine |
Clinical studies and commercial products commonly recommend 200–400 mg of elemental magnesium per day from magnesium lactate. A representative commercial slow-release magnesium lactate tablet contains 84 mg elemental magnesium, with a suggested dose of two tablets twice daily (336 mg/day). For liposomal magnesium formulations, commercial products typically recommend 15 mL (providing 200 mg elemental magnesium) once daily for adults as a maintenance dose. A clinical trial in patients with implantable cardioverter defibrillators used oral magnesium L-lactate at 3 tablets twice daily (504 mg elemental magnesium daily) for 12 months. The Recommended Dietary Allowance (RDA) for elemental magnesium is 310–320 mg/day for adult females and 400–420 mg/day for adult males. The Tolerable Upper Intake Level (UL) for supplemental magnesium is 350 mg/day for adults. Liposomal formulations may allow for more efficient utilization of lower doses due to enhanced bioavailability.
Stock Orders: 3–5 business days after payment confirmation.
Bulk / Custom Orders: 2–3 weeks, depending on quantity and customization requirements.
Shipping Methods: International Express (FedEx, DHL, UPS), air freight, and sea freight.
Coverage: Worldwide shipping, including remote areas.
Magnesium Lactate Encyclopedia — Scientific Background
Magnesium lactate (CAS 18917-93-6 for anhydrous; CAS 179308-96-4 for octahydrate) is the magnesium salt of lactic acid, chemically characterized by the molecular formula C₆H₁₀MgO₆ (anhydrous) and a molecular weight of 202.45 g/mol. The octahydrate form has a molecular weight of 238.48 g/mol. It is produced by complete neutralization of lactic acid with a high-purity magnesium source and subsequent precipitation. The compound occurs as a white crystalline or granular powder that is practically odorless, has a neutral taste, and is soluble in water with good solubility (84 g/L). Magnesium lactate contains approximately 12% elemental magnesium and is a food additive with the European E number E329 and INS number 329.
| Property | Value |
|---|---|
| CAS No. | 18917-93-6 (anhydrous); 179308-96-4 (octahydrate) |
| Molecular Formula | C₆H₁₀MgO₆ (anhydrous); C₆H₁₀MgO₆·8H₂O (octahydrate) |
| Molecular Weight | 202.45 g/mol (anhydrous); 238.48 g/mol (octahydrate) |
| Appearance | White crystalline or granular powder |
| Odor | Practically odorless |
| Taste | Neutral |
| Solubility | Soluble in water (84 g/L) |
| Elemental Magnesium | ~12% |
| E Number | E329 |
| INS No. | 329 |
| Assay (FCC) | 97.5%–101.5% on the dried basis |
Magnesium lactate holds a well-established regulatory position as both a pharmaceutical and food ingredient:
FDA GRAS Status — Magnesium lactate is self-affirmed Generally Recognized As Safe (GRAS) up to 20% of the daily value of magnesium when used in fortified food and beverages and is in full compliance with the US FDA. FDA GRAS Notice GRN 570 covers its intended use as a source of dietary magnesium in fruit-flavored beverages at a level intended to provide 25.2 milligrams of magnesium lactate per serving. Lactic acid and its salts are generally recognized as safe (GRAS) food additives by the FDA under Title 21 of the United States Code of Federal Regulations.
Food Additive — Magnesium lactate functions as a nutrient supplement, acidity regulator, and firming agent with the E number E329 and INS number 329. In the European Union, magnesium lactate (1:2) is listed as food additive E329.
Global Standards — Magnesium lactate conforms to the Food Chemicals Codex (FCC), Joint FAO/WHO Expert Committee on Food Additives (JECFA) specifications, and the Korean Food Additives Code, which specifies assay of 97.5%–101.5% for magnesium L-lactate on the dried basis.
Magnesium is the fourth most abundant cation in the human body and plays an important role in neurochemical transmission and muscular excitability. Key physiological roles include:
Muscle Function — Magnesium regulates muscle contraction and relaxation, and is essential for preventing cramps and spasms
Energy Production — Magnesium is required for ATP synthesis and is a critical cofactor in mitochondrial Energy Metabolism
Nervous System — Magnesium modulates NMDA receptor activity and supports GABAergic function for mood stabilization
Cardiovascular Function — Magnesium regulates heart rhythm, vascular tone, and blood pressure
Bone Health — Approximately 60% of the body's magnesium is stored in bones, where it contributes to bone mineral density
Blood Glucose Regulation — Magnesium is involved in glucose metabolism and insulin signaling
A landmark comparative bioavailability study measured the bioavailability of four commercially available magnesium preparations in normal volunteers using the increment of urinary magnesium excretion. The results demonstrated that magnesium oxide had a fractional absorption of only 4%, while magnesium lactate showed significantly higher absorption equivalent to magnesium chloride and magnesium aspartate. The study concluded that there is relatively poor bioavailability of magnesium oxide, but greater and equivalent bioavailability of magnesium chloride, lactate, and aspartate.
A separate in vitro study using a Caco-2 cell model of the intestinal barrier evaluated the bioavailability and accessibility of magnesium bound in different salt compounds. The study identified significant differences in cell viability between magnesium lactate and other magnesium salts, providing further evidence of the favorable absorption characteristics of magnesium lactate.
The lactate component of magnesium lactate is not merely a carrier—it is a bioactive metabolite with independent physiological benefits. Lactic acid is a natural energy source that muscles and the heart utilize directly. This provides a synergistic benefit: magnesium supports ATP synthesis while lactate can be directly oxidized for energy production, making magnesium lactate particularly suitable for applications targeting muscle function and energy metabolism.
Liposomal encapsulation provides a fundamentally different absorption mechanism. The liposomal phospholipid bilayer is similar to cell membranes in the human body, which makes them progressively biocompatible. liposomes protect magnesium from premature interaction with gastric contents and facilitate efficient cellular delivery via lipid-mediated pathways. The liposomal delivery system bypasses the saturable nature of carrier-mediated magnesium transport, providing an alternative route of cellular entry. In a randomized controlled human clinical trial, liquid liposomal magnesium achieved up to 5.18 times higher bioavailability compared to non-liposomal magnesium in tablet form, with sustained elevated plasma levels maintained throughout the study period.
Liposomal encapsulation of magnesium lactate provides a fundamentally different delivery mechanism from conventional forms. The phospholipid bilayer surrounds the magnesium-lactate complex, forming a protective shell that enhances absorption and enables targeted delivery. This delivery system:
Achieves up to 5.18 times higher bioavailability compared to non-liposomal magnesium in tablet form
Maintains sustained elevated plasma levels throughout the supplementation period
Enhances intestinal absorption through lipid-mediated pathways
Minimizes direct contact between magnesium and the gastrointestinal mucosa
Provides a neutral taste and excellent water dispersibility
A randomized, controlled, two-group human clinical trial enrolled 20 metabolically healthy volunteers to compare the bioavailability of 400 mg magnesium in liquid liposomal form versus non-liposomal tablet form. Magnesium blood plasma levels were measured over time after intake. The results demonstrated that the liquid liposomal magnesium supplement had 5.18 times higher bioavailability than the non-liposomal tablet form and maintained elevated plasma levels throughout the entire study period, proving sustained high concentrations during daily supplementation.
Multiple clinical trials have evaluated magnesium lactate for skeletal muscle cramp relief. A Cochrane systematic review identified trials using 336 mg/day from slow-release magnesium lactate tablets and 366 mg/day from primarily magnesium lactate and magnesium citrate tablets for cramp relief. A double-blind randomized controlled trial in pregnant women suffering from leg cramps used 360 mg/day magnesium oral substitution (magnesium lactate and citrate chewable tablets containing 5 mmol Mg per tablet, taken as one tablet in the morning and two in the evening for 3 weeks).
A placebo-controlled trial randomized 70 patients with an implantable cardioverter defibrillator to receive oral magnesium L-lactate at 3 tablets twice daily (504 mg elemental magnesium daily) or matching placebo for 12 months. Patients were seen at baseline and followed for occurrence of ICD therapies.
A 2018 clinical study using 250 mg/day of magnesium (oxide, gluconate, or lactate) for 3 months demonstrated improvements in glycemic control in type 2 diabetes subjects with a reduction of glycated hemoglobin.
Magnesium lactate is generally well tolerated and is known for its excellent gastrointestinal tolerability. Magnesium lactate is absorbed more easily by the intestines compared to oxide or other inorganic forms, without the laxative side effects commonly associated with magnesium oxide and citrate. It is ideal for people with irritable bowel syndrome (IBS). Common side effects of magnesium supplementation at high doses may include diarrhea, nausea, and abdominal cramping.
The Tolerable Upper Intake Level (UL) for supplemental magnesium is 350 mg/day for adults. Magnesium lactate is self-affirmed Generally Recognized As Safe (GRAS) up to 20% of the daily value of magnesium when used in fortified food and beverages and is in full compliance with the US FDA. It is monographed in the Food Chemicals Codex (FCC) and Korean Food Additives Code. Testing protocols must adhere to international standards including USP, European Pharmacopoeia, and FAO/WHO Codex Alimentarius. Formulators should verify local regulatory requirements prior to market entry.
This product is intended for research, nutraceutical, and functional food applications. Not intended to diagnose, treat, cure, or prevent any disease.
69$/KG
RELATED
RELATED
RELATED
RELATED
This website uses cookies to ensure you get the best experience on our website.
Comment
(0)